Literature DB >> 22689902

Development and validation of a simple and fast HPLC method for determination of lovastatin, pravastatin and simvastatin.

Taízia D Silva1, Marcelo A Oliveira, Renata B de Oliveira, Cristina D Vianna-Soares.   

Abstract

Statins are effective and often-prescribed drugs for the treatment of hypercholesterolemia. This study shows a simple and fast method validation by reversed-phase high-performance liquid chromatography in the linear range 28 to 52 µg/mL to quantify lovastatin, pravastatin sodium or simvastatin in bulk drug or dosage forms. Statins were determined using a C8 endcapped column (250 × 4 mm, 5 µm), isocratic mobile phase of acetonitrile and 0.1% phosphoric acid (65:35), 30°C, ultraviolet-diode array detection at λ 238 nm and 1.5 mL/min flow for lovastatin and simvastatin and 1.0 mL/min for pravastatin sodium. The developed method is fast, simple, reliable and shows appropriate linearity (r > 0.999), accuracy (98.8-101.6%), precision (relative standard deviation <2%) and selectivity toward placebo and/or degradation products in very similar chromatographic conditions for all statins.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22689902     DOI: 10.1093/chromsci/bms079

Source DB:  PubMed          Journal:  J Chromatogr Sci        ISSN: 0021-9665            Impact factor:   1.618


  4 in total

1.  Liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of simvastatin, lovastatin, atorvastatin, and their major metabolites in human plasma.

Authors:  Jiang Wang; Jasmine A Luzum; Mitch A Phelps; Joseph P Kitzmiller
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-01-13       Impact factor: 3.205

2.  Improvement of oral bioavailability of lovastatin by using nanostructured lipid carriers.

Authors:  Jun Zhou; Daxin Zhou
Journal:  Drug Des Devel Ther       Date:  2015-09-18       Impact factor: 4.162

3.  Microemulsion liquid chromatographic method for simultaneous determination of simvastatin and ezetimibe in their combined dosage forms.

Authors:  Mohammed E A Hammouda; Mohamed A Abu El-Enin; Dina T El-Sherbiny; Dalia R El-Wasseef; Saadia M El-Ashry
Journal:  J Anal Methods Chem       Date:  2013-10-27       Impact factor: 2.193

4.  Encapsulation of Lovastatin in Zein Nanoparticles Exhibits Enhanced Apoptotic Activity in HepG2 Cells.

Authors:  Nabil A Alhakamy; Osama A A Ahmed; Hibah M Aldawsari; Mohammad Y Alfaifi; Basma G Eid; Ashraf B Abdel-Naim; Usama A Fahmy
Journal:  Int J Mol Sci       Date:  2019-11-18       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.